ArticleViruses2026
Tiled-Amplicon Whole-Genome Sequencing Method Reveals Endemic Circulation of Human Adenovirus Type 3 in Japan.
Gabriel Gonzalez, Naganori Nao, Koshiro Tabata, Yukari Itakura, Shinji Saito, Kenichiro Takahashi, Masaaki Kobayashi, Nobuyoshi Kitaichi, Nobuhisa Ishiguro, Tsuguto Fujimoto and 3 more
Abstract read
In one paragraphArticle in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Gabriel GonzalezInstitute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo 001-0021, Japan.ORCID 0000-0002-2180-2120 Naganori NaoInstitute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo 001-0021, Japan.
Koshiro TabataInstitute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo 001-0021, Japan.ORCID 0000-0002-0227-2515 Yukari ItakuraInstitute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo 001-0021, Japan.ORCID 0000-0002-3463-1834 Shinji SaitoInstitute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo 001-0021, Japan.
Kenichiro TakahashiJapan Institute for Health Security, National Institute for Infectious Diseases, Tokyo 162-8640, Japan.
Masaaki KobayashiKobayashi Pediatric Clinic, Shizuoka 426-0067, Japan.
Nobuyoshi KitaichiDepartment of Ophthalmology, Health Sciences University of Hokkaido Hospital, Sapporo 002-8072, Japan.
Nobuhisa IshiguroDepartment of Pediatrics, Sophia Kita-Maruyama Clinic, Sapporo 060-0004, Japan.
Tsuguto FujimotoJapan Institute for Health Security, National Institute for Infectious Diseases, Tokyo 162-8640, Japan.ORCID 0000-0002-4861-4349 Hirofumi SawaInstitute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo 001-0021, Japan.
Nozomu HanaokaJapan Institute for Health Security, National Institute for Infectious Diseases, Tokyo 162-8640, Japan.ORCID 0000-0002-1039-6278 Funding
Japan Agency for Medical Research and Development (AMED) JP223fa627005
6 · The paper itselfAbstract
Human adenovirus type 3 (HAdV-3) in the species
Indexed as
Adenoviruses, HumanAdenovirus Infections, HumanWhole Genome SequencingCOVID-19Endemic DiseasesGenome, ViralHumansJapanMastadenovirusPhylogenyRespiratory Tract Infectionsacute respiratory illnessgenome sequencinghuman adenovirus type 3Mastadenovirus blackbeardi
Identifiers
PMID41600839
PMCPMC12846424
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390